GLP-1 receptor agonist

Achmea Ordered to Reimburse Patient for Semaglutide Injections

by
Patient Wins Coverage for Off-Label Weight-Loss Injections

A Dutch regional court ruled on May 28, 2026, that a private health insurer must reimburse a patient for weight-loss injections prescribed by his cardiologist, setting a precedent for off-label use of GLP-1 receptor agonists in obesity treatment under the Dutch Basic Health Insurance Act. Patient Wins Coverage for Off-Label Weight-Loss Injections A Dutch man … Read more

The pharmacodynamics-based prophylactic benefits of GLP-1 receptor agonists and SGLT2 inhibitors on neurodegenerative diseases: evidence from a network meta-analysis | BMC Medicine

by

Avogaro A, de Kreutzenberg SV, Morieri ML, Fadini GP, Del Prato S. Glucose-lowering drugs with cardiovascular benefits as modifiers of critical elements of the human life history. Lancet Diabetes Endocrinol. 2022;10(12):882–9. Article  CAS  PubMed  Google Scholar  Erbil D, Eren CY, Demirel C, Kucuker MU, Solaroglu I, Eser HY. GLP-1’s role in neuroprotection: a systematic review. … Read more